PSMA binding ligand-linker conjugates and methods for using
US10557128B2 · kind B2 · utility
7Cited by
125References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2018 |
| Grant date | Feb 11, 2020 |
| Priority date | — |
| Expiry date | Mar 24, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/17021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical compositions containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.